TREM2 and Alzheimer disease: Recent genetic data strongly support the key role of inflammation and immune-related genes in AD pathogenesis by demonstrating that a mutation in the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) confers a very high likelihood to develop AD (Basha et al., 2023).